Gender differences in amniotic fluid cytokine levels

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 15, Issue 6, 2004, Pages 367-371

  Poggi, S H ^a,b,c   Spong, C Y ^a,b   Ghidini, A ^a   Ossandon, M ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenin; Fetal gender; IL 10; IL 6; Mid trimester amniocentesis; Preterm delivery

Indexed keywords

ANGIOGENIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PROSPECTIVE STUDIES; RIBONUCLEASE, PANCREATIC; SEX FACTORS;

EID: 4043049460     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050410001727396     Document Type: Article

References (41)

1. Lumley J. Defining the problem: the epidemiology of preterm birth. Br J Obstet Gynaecol 2003;100:3-7
2. Ward RM, Beachy JC. Neonatal complications following preterm birth. Br J Obstet Gynaecol 2003;110:8-16
3. Moutquin JM. Classification and heterogeneity of preterm birth. Br J Obstet Gynaecol 2003;110:30-3
4. Cooperstock M, Campbell J. Excess males in preterm birth: interactions with gestational age, race, and multiple births. Obstet Gynecol 1996;88:189-93
5. McGregor JA, Leff M, Orleans M, Baron A. Fetal gender differences in preterm birth: finding in a North American cohort. Am J Perinatol 1992;9:43-8
6. Astolfi P, Zonta LA. Risks of preterm delivery and association with maternal age, birth order, and fetal gender. Hum Reprod 1999;14:2891-4
7. Ingemarsson I. Gender aspects of preterm birth. Br J Obstet Gynaecol 2003;110:34-8
8. Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130-6
9. Ogunyemi D, Murillo M, Jackson U, et al. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med 2003;13:102-9
10. Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell counts, glucose, interleukin-6, and gram stain in patients with preterm delivery and intact membranes. Am J Obstet Gynecol 1993;169:805-16
11. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25
12. Dollner H, Vatten L, Halgunset J, et al. Histologic choriamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. Br J Obstet Gynaecol 2002;109:534-9
13. Fukuda H, Masuzaki H, Ishimaru T. Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with preterm, premature rupture of membranes. Int J Gynaecol Obstet 2002;77:123-9
14. Romero R, Mazor M, Brandt F, et al. Interleukin-1 alpha and interluekin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992;27:117-23
15. Bry K, Lappalainen U, Waffarn F, et al. Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine. Pediatr Res 1994;35:130-4
16. Wenstrom KD, Andrews WW, Tamura T, et al. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 1996;175:830-3
17. Wenstrom KD, Andrews WW, Hauth JC, et al. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998;178:546-50
18. Ghidini A, Jenkins CB, Spong CY, et al. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol 1997;37:227-31
19. Greig PC, Herbert WN, Robinette BL, Teot LA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995;173:1223-7
20. Spong CY, Ghidini A, Sherer DM, et al. Angiogenin: a marker for preterm delivery in mid-trimester amniotic fluid. Am J Obstet Gynecol 1997;177:483-4
21. Madazli R, Atis A, Uzun H, Aksu F. Midtrimester amniotic fluid angiogenin, lactate dehydrogenase and fibronectin in the prediction of preterm delivery. Eur J Obsetet Gynecol Reprod Biol 2003;106:160-4
22. Riordan JF. Angiogenin. Methods Enzymol 2001;341:263-73
23. Vallee BL, Riordan JF. Organogenesis and angiogenin. Cell Mol Life Sci 1997;10:803-15
24. Badet J, Soncin F, Guitton JD, et al. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci USA 1989;21:8427-31
25. Rajashekhar G, Loganath A, Roy AC, Wong, YC. Expression and localization of angiogenin in placenta: enhanced levels at term over first trimester villi. Mol Reprod Dev 2002;63:159-66
26. Rajashekhar G, Loganath A, Roy AC, Wong YC. Overexpression and secretion of angiogenin in intrauterine growth retardation placenta. Mol Reprod Dev 2003;64:397-404
27. Ghidini A, Salafia CM, Patane L. Sexual origin of placental dysfunction in severe prematurity. Am J Obstet Gynecol 2001;184:S49
28. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy. Review of a new approach. Pharmacol Rev 2003;55:241-69
29. Danzer H, Braustein GD, Rasor J, et al. Maternal serum human chorionic gonadotropin concentrations and fetal sex prediction. Fertil Steril 1980;34:336-40
30. Leporier N, Herrol M, Lemarie P. Shift of the fetal sex ratio in hCG selected pregnancies at risk for Down Syndrome [Letter]. Prenat Diagn 1992;12:703-4
31. Bazzett LB, Yaron Y, O'Brien JE, et al. Fetal gender impact on multiple-marker screening results. Am J Med Genet 1998;76:369-71
32. Askling J, Erlandsson G, Kaijser M, et al. Sickness in pregnancy and sex of child [Letter]. Lancet 1999;354:2053
33. Islami D, Mock P, Bischof P. Effects of human chorionic gonadotropin on trophoblast invasion. Semin Reprod Med 2001;19:49-53
34. Zygmunt M, Herr F, Munstedt K, et al. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;110:S10-18
35. Zygmunt M, Herr F, Keller-Schoenwetter S, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002;87:5290-6
36. Spinillo A, Capuzzo E, Nicola S, et al. Interaction between fetal gender and risk factors for fetal growth retardation. Am J Obstet Gynecol 1994;171:1273-7
37. Divon MY, Ferber A, Nisell H, Westgren W. Male gender predisposes to prolongation of pregnancy. Am J Obset Gynecol 2002;187:1081-3
38. Haddad B, Mercer BM, Livingston JC, Sibai BM. Obstetric antecedents to apparent stillbirth (Apgar score zero at 1 minute only). Obstet Gynecol 2001;97:961-4
39. James WH. Sex ratios of offspring and the causes of placental pathology. Hum Reprod 1995;10:1403-6
40. Steier JA, Ulstein M, Myking OL. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstet Gynecol 2002;100:552-6
41. Kramer MS, Usher RH, Pollack R, et al. Etiologic determinants of abruptio placentae. Obstet Gynecol 1997;89:221-6